Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 08, 2026

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 339.40	3.4%	24.9%	CHF 289.7b	CHF 333.65	PE30.6x	E12.8%	2.9%
NOVN Novartis	CHF 113.76	3.8%	24.1%	CHF 218.3b	CHF 109.79	PE19x	E7.5%	2.7%
LONN Lonza Group	CHF 552.00	2.6%	-0.9%	CHF 38.8b	CHF 675.82	PE52.9x	E18.7%	0.7%
GALD Galderma Group	CHF 163.20	0.7%	52.6%	CHF 38.7b	CHF 164.67	PE128.2x	E27.0%	0.08%
SDZ Sandoz Group	CHF 60.54	4.7%	54.9%	CHF 26.1b	CHF 54.98	PE143.7x	E25.3%	0.9%
DESN Dottikon ES Holding	CHF 360.50	3.4%	64.6%	CHF 5.0b	CHF 460.00	PE41.2x	n/a	0%
BANB Bachem Holding	CHF 62.30	4.0%	5.6%	CHF 4.7b	CHF 73.39	PE34.8x	E15.5%	1.4%
SFZN Siegfried Holding	CHF 79.60	6.7%	-19.9%	CHF 3.5b	CHF 108.67	PE22.6x	E10.7%	0.5%
TECN Tecan Group	CHF 140.20	9.1%	-37.3%	CHF 1.8b	CHF 192.57	PE28.2x	E13.5%	2.1%
COPN Cosmo Pharmaceuticals	CHF 110.00	4.6%	70.0%	CHF 1.8b	CHF 97.78	PE31.4x	E35.2%	1.7%
SKAN SKAN Group	CHF 54.90	4.0%	-29.1%	CHF 1.2b	CHF 70.33	PE76.3x	E32.8%	0.7%
KURN Kuros Biosciences	CHF 27.50	0.07%	17.3%	CHF 1.1b	CHF 32.80	PS10.4x	E60.9%	n/a
IDIA Idorsia	CHF 3.76	-11.8%	373.5%	CHF 937.8m	CHF 5.00	PS4x	E26.8%	n/a
PPGN PolyPeptide Group	CHF 27.25	4.4%	-4.7%	CHF 899.0m	CHF 34.36	PS2.6x	E65.3%	0%
BSLN Basilea Pharmaceutica	CHF 56.60	3.5%	32.1%	CHF 695.5m	CHF 90.78	PE9.6x	E-22.6%	0%
NWRN Newron Pharmaceuticals	CHF 28.45	19.3%	225.9%	CHF 569.4m	CHF 30.59	PE24.1x	E34.4%	n/a
MMTX MindMaze Therapeutics Holding	CHF 1.56	-17.9%	n/a	CHF 238.1m	CHF 3.56	n/a	n/a	n/a
SANN Santhera Pharmaceuticals Holding	CHF 13.58	7.8%	-3.6%	CHF 181.6m	CHF 30.00	PS3.7x	S48.7%	n/a
XLS Xlife Sciences	CHF 26.00	5.3%	0%	CHF 150.0m	n/a	PE4.9x	n/a	n/a
BIOV BioVersys	CHF 23.40	-4.1%	n/a	CHF 136.8m	CHF 55.00	PS104.5x	E-15.5%	n/a
MOLN Molecular Partners	CHF 3.31	-2.2%	-28.6%	CHF 123.8m	CHF 9.00	PB1.3x	E-4.1%	n/a
CURN Curatis Holding	CHF 13.20	10.0%	1.5%	CHF 68.0m	CHF 98.10	n/a	n/a	n/a
ADXN Addex Therapeutics	CHF 0.055	0%	-8.0%	CHF 6.5m	n/a	PS40.7x	n/a	n/a